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OPINION
World Malaria Report: time 
to acknowledge Plasmodium knowlesi malaria
Bridget E. Barber1,2* , Giri S. Rajahram2,3, Matthew J. Grigg1,2, Timothy William2,4 and Nicholas M. Anstey1,2
Abstract 
Background: The 2016 World Health Organization (WHO) World Malaria Report documents substantial progress 
towards control and elimination of malaria. However, major challenges remain. In some regions of Southeast Asia, the 
simian parasite Plasmodium knowlesi has emerged as an important cause of human malaria, and the authors believe 
this species warrants regular inclusion in the World Malaria Report.
Main text: Plasmodium knowlesi is the most common cause of malaria in Malaysia, and cases have also been 
reported in nearly all countries of Southeast Asia. Outside of Malaysia, P. knowlesi is frequently misdiagnosed by 
microscopy as Plasmodium falciparum or Plasmodium vivax. Thus, P. knowlesi may be underdiagnosed in affected 
regions and its true incidence underestimated. Acknowledgement in the World Malaria Report of the regional impor-
tance of P. knowlesi will facilitate efforts to improve surveillance of this emerging parasite. Furthermore, increased rec-
ognition will likely lead to improved delivery of effective treatment for this potentially fatal infection, as has occurred 
in Malaysia where P. knowlesi case-fatality rates have fallen despite rising incidence. In a number of knowlesi-endemic 
countries, substantial progress has been made towards the elimination of P. vivax and P. falciparum. However, efforts 
to eliminate these human-only species should not preclude efforts to reduce human malaria from P. knowlesi. The 
regional importance of knowlesi malaria was recognized by the WHO with its recent Evidence Review Group meeting 
on knowlesi malaria to address strategies for prevention and mitigation.
Conclusion: The WHO World Malaria Report has an appropriate focus on falciparum and vivax malaria, the major 
causes of global mortality and morbidity. However, the authors hope that in future years this important publication 
will also incorporate data on the progress and challenges in reducing knowlesi malaria in regions where transmission 
occurs.
Keywords: Plasmodium knowlesi, Malaria, World Malaria Report, Malaysia
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The recently released 2016 World Malaria Report, pub-
lished by the World Health Organization (WHO), 
documents substantial progress towards control and 
elimination of malaria [1]. Malaria incidence rate has 
declined by 41% since 2000, and 21% since 2010. Mor-
tality has fallen by 61% since 2000, and 29% since 2015. 
Seventeen countries eliminated malaria between 2000 
and 2015, with a further 13 countries “approaching elimi-
nation.” These data represent significant achievements; 
however, major challenges remain. Challenges discussed 
in the World Malaria Report include the development 
and spread of mosquito resistance to insecticides, resist-
ance to artemisinins and their partner drugs, and fund-
ing shortfalls. In Southeast Asia the emerging zoonotic 
malaria species Plasmodium knowlesi is an additional 
challenge that warrants regular inclusion in the World 
Malaria Report.
Main text
Plasmodium knowlesi was reported as a major cause of 
human malaria in Sarawak, Malaysia, in a seminal paper 
published 13 years ago [2], and it is now the most com-
mon cause of malaria in this country [3, 4]. Cases have 
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been increasingly reported elsewhere in Southeast Asia, 
including Indonesia, Thailand, Vietnam, and Myanmar, 
and in returned travellers [5, 6]. In the west of Indonesia, 
a country with an estimated 1.3 million malaria cases in 
2015 [1], emerging evidence suggests that at least in some 
districts, P. knowlesi may now be the predominant Plas-
modium species [7, 8]. In these regions limited evidence 
suggests that nearly all P. knowlesi cases are diagnosed by 
microscopy as Plasmodium falciparum or Plasmodium 
vivax [7, 8]. Thus, under-diagnosis of P. knowlesi may be 
common and incidence may be significantly underesti-
mated across affected regions.
While mentioned in some previous editions of the 
World Malaria Report, P. knowlesi is not acknowledged 
in the 2016 Report. Regular inclusion of knowlesi malaria 
in the World Malaria Report, and acknowledgment of the 
importance of P. knowlesi as a cause of human malaria in 
parts of Southeast Asia, will facilitate efforts to increase 
recognition and improve surveillance of this emerging 
parasite.
Plasmodium knowlesi is a highly pathogenic malaria 
parasite in humans, with a low pyrogenic threshold and 
a risk of severe disease that in adults appears at least as 
high as that of P. falciparum [9]. In Malaysia, prior to 
widespread recognition of P. knowlesi, misdiagnosis of P. 
knowlesi was associated with delayed administration of 
parenteral therapy, and high fatality rates were reported 
[10, 11]. Increased recognition of P. knowlesi has led 
to more timely delivery of optimal treatment and has 
likely contributed to the reported sixfold reduction in P. 
knowlesi case-fatality rates [12].
In the 2016 World Malaria Report, Malaysia is listed 
as one of 13 countries approaching elimination. Elimina-
tion is defined as the interruption of local transmission 
of a specified malaria parasite in a defined geographic 
area, and in Malaysia, efforts have focussed on P. vivax 
and P. falciparum [13]. Indeed, Malaysia has made sub-
stantial progress in controlling these species [3, 14], and 
appears on track to approach elimination of human-only 
species by 2020. However, efforts to eliminate P. vivax 
and P. falciparum should not preclude efforts to control 
P. knowlesi. The WHO Malaria Policy Advisory Commit-
tee (MPAC) recognized the regional importance of this 
species by endorsing the creation of an Evidence Review 
Group on P. knowlesi, to address key gaps in knowledge 
and to “advise a path to malaria elimination that includes 
P. knowlesi” and to develop “appropriate mitigating and 
preventative strategies” [15]. Such strategies are likely to 
differ from those used for control of P. vivax and P. falci-
parum, and further research to increase recognition and 
identify effective interventions to limit transmission of 
P. knowlesi is required. The authors welcome the recent 
convening of the WHO Expert Consultation Meeting on 
knowlesi malaria, at which these issues were discussed.
Conclusions
The role of the World Malaria Report is to educate and 
inform, to document progress and identify future chal-
lenges for controlling and eliminating malaria. While it 
is appropriate to focus on falciparum and vivax malaria, 
the major causes of global mortality and morbidity, the 
authors hope that in future years this important report 
will also incorporate data on progress and challenges 
in controlling knowlesi malaria in those regions where 
transmission occurs.
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